Amplification of LAPTM4B, which contributes to chemotherapy resistance and recurrence of breast cancer [30, 31] and other solid tumors [32] was over-expressed in our TKI-resistant CML cases. The gene discussed is LAPTM4B; the disease is breast carcinoma.